Drug Trial Radar · NCT07446322
FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal Cancer
Last checked: Nov 19, 2026Latest source record: Nov 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
60
Planned (sponsor's estimate)
Start
Apr 30, 2026
Primary completion
Aug 30, 2027
Study completion Apr 30, 2030
Sponsor
- Lead sponsor
- Oncolytics BiotechIndustry
- Sponsor type
- Industry
- First posted
- Mar 3, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is an open-label, randomized, multicenter Phase 2 study to assess the efficacy and safety of FOLFIRI + bevacizumab + pelareorep vs. FOLFIRI + bevacizumab in patients with RAS-mutated, MSS mCRC who have progressed after one prior line of oxaliplatin-based therapy.
Conditions
- Ras-mutated Metastatic Colorectal Cancer
- mCRC
- MSS Metastatic Colorectal Cancer
Interventions
BevacizumabDrug
Bevacizumab (5 mg/kg) IV infusion
FOLFIRIDrug
irinotecan (180mg/m2), leucovorin 400 mg/m2 ± 5-FU (400 mg/m2) IV infusion
PelareorepDrug
pelareorep 4.5 x 10\^10 TCID50 IV infusion
Primary outcomes
What the sponsor says the trial is designed to measure.
- Overall Response Rate (ORR)Time frame: At week 8
Locations
20 sites in 1 country. Site status is shown where the registry gives one.
Central Alabama Research
Homewood, Alabama · Recruiting
Clinical Research Advisors (Beverly Hills)
Beverly Hills, California · Recruiting
Clinical Research Advisors (Encino)
Encino, California · Recruiting
Clinical Research Advisors (Korea Town)
Koreatown, California · Recruiting
Clinical Research Advisors (Downtown LA)
Los Angeles, California · Recruiting
Clinical Research Advisors (West Hollywood)
Los Angeles, California · Recruiting
Clinical Research Advisors (West Covina)
West Covina, California · Recruiting
Moffitt Cancer Center
Tampa, Florida · Recruiting
Emory Winship Cancer Institute
Atlanta, Georgia · Recruiting
Beacon Cancer Center
Post Falls, Idaho · Recruiting
Northwestern Memorial Hospital
Chicago, Illinois · Recruiting
Community Health Network
Indianapolis, Indiana · Recruiting
Karmanos Cancer Institute
Detroit, Michigan · Recruiting
Washington University School of Medicine
St Louis, Missouri · Recruiting
Summit Health Cancer Center
Florham Park, New Jersey · Recruiting
Rutgers Cancer Institute
New Brunswick, New Jersey · Recruiting
Gabrail Cancer Center
Canton, Ohio · Recruiting
University of Cincinnati Medical Center
Cincinnati, Ohio · Recruiting
Ohio State University
Colombus, Ohio · Recruiting
The University of Texas MD Anderson Cancer Center
Houston, Texas · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.